Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 4, 2009, Pages 252-255

  Danko, Janine R ^a   Gilliland, William R ^b   Miller, R Scott ^c   Decker, Catherine F ^d  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; INFLIXIMAB; ISONIAZID; MELOXICAM; METHOTREXATE; MOXIFLOXACIN; PARACETAMOL; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BLOOD CELL COUNT; BONE NECROSIS; CASE REPORT; CELL INFILTRATION; DISEASE DURATION; DISEASE EXACERBATION; DNA PROBE; DRUG WITHDRAWAL; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GASTROCNEMIUS MUSCLE; GRANULOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; KNEE PAIN; LOW DRUG DOSE; MYCOBACTERIOSIS; MYCOBACTERIUM MARINUM; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PHYSICAL EXAMINATION; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN DEFECT; SKIN NODULE; TUBERCULOSIS; ATYPICAL MYCOBACTERIOSIS; BACTERIAL SKIN DISEASE; DRUG ANTAGONISM; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM MARINUM; SKIN DISEASES, BACTERIAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66849111150     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540902774599     Document Type: Article

References (16)

1. Wallis, RS, Broder, MS, Wong, JY, Hanson, ME and Beenhouwer, DO. (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Inf Dis, 38, pp. 1261-1265.
2. Bongartz, T., Sutton, A., Sweeting, MJ, Buchan, I., Matteson, EL and Montori, V. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. JAMA, 295, pp. 2275-2285.
3. Dixon, WG, Watson, K., Lunt, M., Hyrich, KL, Silman, AJ and Symmons, DP. (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy. Arthritis and Rheumatism, 34, pp. 2368-2376.
4. Lam, A., Wadie, T. and Schlesinger, N. (2006) Mycobacterium marinum arthritis mimicking rheumatoid arthritis. J Rheumatol, 33, pp. 817-819.
5. Brown III, JW and Sanders, CV. (1987) Mycobacterium marinum infections: a problem of recognition, not therapy?. Arch Intern Med, 147, pp. 817-818.
6. Jernigan, JA and Farr, BM. (2000) Incubation period and source of exposure for cutaneous Mycobacterium marinum infections: Case report and review of the literature. Clin Infect Dis, 31, pp. 439-443.
7. Mufti, AH, Toye, BW, McKendry, R. and Angel, JB. (2005) Mycobacterium abscessus infection after use of tumor necrosis factor-α inhibitor therapy: Case report and review of infectious complications associated with tumor necrosis factor-α use. Diagn Micro Infect Dis, 53, pp. 233-238.
8. Alloway, JA, Evangelisti, SM and Sartin, JS. (1995) Mycobacterium marinum arthritis. Sem Arthr Rheum, 24, pp. 382-390.
9. Ho, PL, Ho, P., Fung, BK-K, Ip, WY and Wong, SS. (2001) A case of disseminated Mycobacterium marinum infection following systemic steroid therapy. Scand J Infect Dis, 33, pp. 232-233.
10. Enzensberger, R., Hunfield, KP, Elshorst-Schmidt, T., Boer, A. and Brade, V. (2002) Disseminated cutaneous Mycobacterium marinum infection in a patient with non-Hodgkin's lymphoma. Infection, 30, pp. 393-395.
11. Parent, LJ, Salam, MM, Appelbaum, PC and Dossett, JH. (1995) Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency. Clin Infect Dis, 21, pp. 1325-1327.
12. Edelstein, H. (1994) Mycobacterium marinum skin infections: A report of 31 cases and review of the literature. Arch Int Med, 154, pp. 1359-1364.
13. Casal, M. and Casal, MM. (2001) Multicenter study of incidence of Mycobacterium marnium in humans in Spain. Int J Tuberc Lung Dis, 5, pp. 197-199.
14. Ang, P., Rattana-Apiromyakij, N. and Goh, CL. (2000) Retrospective study of Mycobacterium marinum skin infections. Int J Dermatol, 39, pp. 343-347.
15. Aubry, A., Chosidow, O., Caumes, E., Robert, J. and Cambau, E. (2002) 63 cases of Mycobacterium marinum infection. Arch Int Med, 162, pp. 1746-1752.
16. Enzenauer, RJ, McKoy, J., Vincent, D. and Gates, R. (1990) Disseminated cutaneous and synovial Mycobacterium marinum infection in a patient with systemic lupus erythematosus. South Med Jrnl, 83, pp. 471-474.